# Neural Respiratory Drive of Patients With Chronic Obstructive Pulmonary Disease

> **NCT05786950** · NA · COMPLETED · sponsor: **The First Affiliated Hospital of Guangzhou Medical University** · enrollment: 44 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** compound ipratropium bromide solution (3mg salbutamol and 500μg ipratropium, Boehringer Ingelheim Limited, Germany)

## Key facts

- **NCT ID:** NCT05786950
- **Lead sponsor:** The First Affiliated Hospital of Guangzhou Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-01
- **Primary completion:** 2023-07-01
- **Final completion:** 2024-09-01
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2025-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05786950

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05786950, "Neural Respiratory Drive of Patients With Chronic Obstructive Pulmonary Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05786950. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*